Insider Stock Trading History of Myers Scott Dunseth


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Myers Scott Dunseth since year 2005. The trader's CIK number is 1356256. At the time of this reporting, Myers Scott Dunseth is the President and CEO of Cascadian Therapeutics, Inc. . (stock ticker symbol CASC). See this page for all insider trading activities at Cascadian Therapeutics, Inc. .

Note that in the past Myers Scott Dunseth also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Myers Scott Dunseth since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-11 CASC Cascadian Therapeutics, Inc. Option Ex 10,500 .00 0
2017-08-11 CASC Cascadian Therapeutics, Inc. Buy 5,500 3.73 20,542
2017-05-12 CASC Cascadian Therapeutics, Inc. Buy 2,800 4.00 11,191
2017-03-31 CASC Cascadian Therapeutics, Inc. Buy 2,000 4.11 8,228
2017-03-20 CASC Cascadian Therapeutics, Inc. Buy 1,000 3.93 3,927
2017-01-27 CASC Cascadian Therapeutics, Inc. Buy 20,500 3.76 77,039
2016-08-17 CASC Cascadian Therapeutics, Inc. Buy 45,000 1.15 51,749
2016-06-28 CASC Cascadian Therapeutics, Inc. Buy 62,500 .80 50,000
2006-05-24 DOVP Dov Pharmaceutical Inc Buy 5,000 2.69 13,450
2006-05-25 DOVP Dov Pharmaceutical Inc Buy 5,000 2.69 13,450

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Myers Scott Dunseth (President and CEO of Cascadian Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.